Shao Z - Search Results

1

Optimal Duration of Neoadjuvant Taxane and Carboplatin Combined With Anti-HER2 Targeted Therapy for HER2-Positive Breast Cancer.

Xie Y, Wu S, Zhang Y, Li J, Mo M, Shao Z, Liu G. Xie Y, et al. Among authors: shao z. Front Oncol. 2021 Jun 8;11:686591. doi: 10.3389/fonc.2021.686591. eCollection 2021. Front Oncol. 2021. PMID: 34168999 Free PMC article.

2

[Sentinel lymph node biopsy in breast cancer].

Shen K, Nirmal L, Han Q, Wu J, Lu J, Zhang J, Liu G, Shao Z, Shen Z. Shen K, et al. Among authors: shao z. Zhonghua Wai Ke Za Zhi. 2002 May;40(5):347-50. Zhonghua Wai Ke Za Zhi. 2002. PMID: 12133338 Chinese.

3

[Lymphoscintigraphy in sentinel lymph node biopsy of breast cancer].

Zhang J, Shen K, Nirmal L, Liu G, Wu J, Zhang Y, Du H, Pan Z, Shao Z, Shen Z. Zhang J, et al. Among authors: shao z. Zhonghua Zhong Liu Za Zhi. 2002 Nov;24(6):616-8. Zhonghua Zhong Liu Za Zhi. 2002. PMID: 12667340 Chinese.

4

Time-varying pattern of recurrence risk for Chinese breast cancer patients.

Yin W, Di G, Zhou L, Lu J, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z. Yin W, et al. Among authors: shao z. Breast Cancer Res Treat. 2009 Apr;114(3):527-35. doi: 10.1007/s10549-008-0022-5. Epub 2008 Apr 19. Breast Cancer Res Treat. 2009. PMID: 18425576

5

Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months.

Huang O, Chen C, Wu J, Chen S, Chen X, Liu G, Hu Z, Lu J, Wu J, Shao Z, Shen Z, Shen K. Huang O, et al. Among authors: shao z. BMC Cancer. 2009 Oct 21;9:375. doi: 10.1186/1471-2407-9-375. BMC Cancer. 2009. PMID: 19845944 Free PMC article.

6

Using peripheral blood mRNA signature to distinguish between breast cancer and benign breast disease in non-conclusive mammography patients.

Yang B, Xu Q, Wu F, Liu F, Ye X, Liu G, Shao Z, Meng X, Mougin B, Wu J. Yang B, et al. Among authors: shao z. Cancer Biol Ther. 2010 Dec 15;10(12):1235-9. doi: 10.4161/cbt.10.12.13437. Epub 2010 Dec 15. Cancer Biol Ther. 2010. PMID: 20930549 Free article.

7

Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapy.

Chen Y, Chen C, Yang B, Xu Q, Wu F, Liu F, Ye X, Meng X, Mougin B, Liu G, Shen Z, Shao Z, Wu J. Chen Y, et al. Among authors: shao z. Cancer Lett. 2011 Mar 1;302(1):63-8. doi: 10.1016/j.canlet.2010.12.014. Epub 2011 Jan 8. Cancer Lett. 2011. PMID: 21220187

8

18F-fluoromisonidazole PET/CT: a potential tool for predicting primary endocrine therapy resistance in breast cancer.

Cheng J, Lei L, Xu J, Sun Y, Zhang Y, Wang X, Pan L, Shao Z, Zhang Y, Liu G. Cheng J, et al. Among authors: shao z. J Nucl Med. 2013 Mar;54(3):333-40. doi: 10.2967/jnumed.112.111963. Epub 2013 Feb 11. J Nucl Med. 2013. PMID: 23401605 Free article.

9

The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluation.

Li JJ, Chen C, Gu Y, Di G, Wu J, Liu G, Shao Z. Li JJ, et al. Among authors: shao z. PLoS One. 2014 Feb 11;9(2):e88853. doi: 10.1371/journal.pone.0088853. eCollection 2014. PLoS One. 2014. PMID: 24523942 Free PMC article. Clinical Trial.

10

Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer.

Sun S, Tang L, Zhang J, Lv F, Wang Z, Wang L, Zhang Q, Zheng C, Qiu L, Jia Z, Lu Y, Liu G, Shao Z, Wang B, Hu X. Sun S, et al. Among authors: shao z. Int J Nanomedicine. 2014 Mar 19;9:1443-52. doi: 10.2147/IJN.S58275. eCollection 2014. Int J Nanomedicine. 2014. PMID: 24672237 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,660 results

Search Page

Filters